Add BrightSurf on Google Email

Jekyll and Hyde and seek

A signaling protein called Daple, normally a tumor suppressor, can be manipulated by growth factors to become a driver of malignant growth and metastasis in cancer cells. This discovery highlights the complexity of crosstalk between major signals that drive cancers.

SourceUniversity of California - San Diego·JournalScience Signaling·DateFeb 27, 2018

Catching up to brain cancer

Researchers create a computer program that predicts glioblastoma tumor growth with high accuracy, focusing on the role of L1CAM in accelerating cell spread. The model offers new opportunities for researchers to simulate various scenarios and test potential treatments.

SourceUniversity of Delaware·JournalBMC Biology·DateFeb 15, 2018

Stealth virus for cancer therapy

Researchers have created a stealth virus that effectively recognizes and infects tumor cells using adapter molecules. The virus is protected by a novel protein shield that prevents immune system elimination, opening up avenues for treating aggressive cancers.

SourceUniversity of Zurich·JournalNature Communications·DateJan 31, 2018

Multifunctional platform for the delivery of gene therapeutics

Researchers have developed a multifunctional vehicle using gold nanoparticles to transport and release the CRISPR-Cas9 system for targeted gene editing in tumors. The platform combines hyperthermal cancer therapy with genetic modification, offering a promising approach for tumor therapy.

SourceWiley·JournalAngewandte Chemie International Edition·DateJan 22, 2018

NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures

Scientists at NIST have discovered a way to make tiny colonies of cells grow in three-dimensional structures inside petri dishes, paving the way for more realistic biological environments for testing pharmaceuticals. The method could help bridge the gap between lab and living creature testing, speeding up drug development.

SourceNational Institute of Standards and Technology (NIST)·JournalACS Biomaterials Science & Engineering·DateNov 16, 2017

Brain tumors share common tricks to survive

Researchers discovered that different types of brain tumors and brain cancer cells share common energy production processes, enabling them to adapt and grow in the brain. This study aims to identify new targets for treatment and potentially develop drugs specifically designed to target these survival mechanisms.

SourceCancer Research UK·JournalPLOS ONE·DateOct 25, 2017

New approaches in targeted cancer therapy

Researchers at Cologne University Hospital have discovered a novel inhibitor that specifically targets NMC tumours, a rare and lethal form of cancer. The study's findings provide valuable insights into the molecular mechanism responsible for the effectiveness of the inhibitor, paving the way for new and improved therapies.

SourceUniversity of Cologne·JournalCell Reports·DateSep 26, 2017

When good immune cells turn bad

Researchers at Children's Hospital Los Angeles identified a molecular pathway in an immune cell called a tumor-associated macrophage that supports neuroblastoma, a pediatric cancer. Targeting the STAT3 pathway with a clinically available drug may be a promising approach to improve outcomes for children with high-risk neuroblastoma.

SourceChildren's Hospital Los Angeles·JournalOncoTargets and Therapy·DateSep 21, 2017

Mitochondrial metastasis suppressor pathway controls tumor cell metabolic reprogramming

Researchers at The Wistar Institute have discovered a novel metastasis suppressor pathway orchestrated by the mitochondrial protein SNPH. This pathway promotes tumor cell proliferation in local growth but inhibits invasion and metastasis. By studying SNPH, scientists may uncover new therapeutic approaches to target metastatic cells.

SourceThe Wistar Institute·JournalJournal of Clinical Investigation·DateSep 11, 2017